KR20240052799A - 폐질환을 치료 및 예방하기 위한 조성물 및 방법 - Google Patents

폐질환을 치료 및 예방하기 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20240052799A
KR20240052799A KR1020247009792A KR20247009792A KR20240052799A KR 20240052799 A KR20240052799 A KR 20240052799A KR 1020247009792 A KR1020247009792 A KR 1020247009792A KR 20247009792 A KR20247009792 A KR 20247009792A KR 20240052799 A KR20240052799 A KR 20240052799A
Authority
KR
South Korea
Prior art keywords
seq
asthma
peptide
clause
purified peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247009792A
Other languages
English (en)
Korean (ko)
Inventor
줄리 레드포드
모니카 크라프트
조세프 바그너
Original Assignee
아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나
래세도, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/409,642 external-priority patent/US20210379141A1/en
Application filed by 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나, 래세도, 엘엘씨 filed Critical 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나
Priority claimed from PCT/US2022/075356 external-priority patent/WO2023028491A1/en
Publication of KR20240052799A publication Critical patent/KR20240052799A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020247009792A 2021-08-23 2022-08-23 폐질환을 치료 및 예방하기 위한 조성물 및 방법 Pending KR20240052799A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/409,642 2021-08-23
US17/409,642 US20210379141A1 (en) 2016-04-11 2021-08-23 Compositions and methods for treating and preventing lung disease
PCT/US2022/075356 WO2023028491A1 (en) 2021-08-23 2022-08-23 Compositions and methods for treating and preventing lung disease

Publications (1)

Publication Number Publication Date
KR20240052799A true KR20240052799A (ko) 2024-04-23

Family

ID=85278728

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247009792A Pending KR20240052799A (ko) 2021-08-23 2022-08-23 폐질환을 치료 및 예방하기 위한 조성물 및 방법

Country Status (6)

Country Link
EP (1) EP4392052A4 (https=)
JP (1) JP2024532412A (https=)
KR (1) KR20240052799A (https=)
CN (1) CN118076372A (https=)
AU (1) AU2022332283A1 (https=)
CA (1) CA3175945A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017180546A1 (en) * 2016-04-11 2017-10-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
EP4132470A4 (en) * 2020-04-08 2023-11-08 Arizona Board of Regents on behalf of the University of Arizona COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASES

Also Published As

Publication number Publication date
AU2022332283A1 (en) 2024-03-07
CA3175945A1 (en) 2023-02-23
EP4392052A1 (en) 2024-07-03
CN118076372A (zh) 2024-05-24
JP2024532412A (ja) 2024-09-05
EP4392052A4 (en) 2025-07-23

Similar Documents

Publication Publication Date Title
US11110152B2 (en) Compositions and methods for treating and preventing lung disease
KR101862291B1 (ko) 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
KR102588702B1 (ko) 누트린-3a 및 펩티드에 의한 폐 섬유증의 저해
US20230190861A1 (en) Peptide therapeutics for acute and chronic airway and alveolar diseases
JP7719590B2 (ja) Ｔｌｒアゴニストによる呼吸器感染症の治療
US9301994B2 (en) LIGHT inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
EP3288960B1 (en) Short synthetic peptide for treatment and/or prophylaxis of autoimmune and inflammatory disorders
CN103200955A (zh) 包含肽和病毒神经氨酸酶抑制剂的组合物
US20240082342A1 (en) Peptide therapeutics for increasing lung cell viability
KR20170044171A (ko) 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
US20240269242A1 (en) Compositions and methods for treating and preventing lung disease
KR20240052799A (ko) 폐질환을 치료 및 예방하기 위한 조성물 및 방법
US20230135877A1 (en) Compositions and methods for treating and preventing lung disease
US20110192396A1 (en) Pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease
WO2023028491A1 (en) Compositions and methods for treating and preventing lung disease
KR20180058843A (ko) 짧은 합성 펩티드 및 그의 용도
US20210379141A1 (en) Compositions and methods for treating and preventing lung disease
RU2737799C1 (ru) Ингаляционный гексапептид для лечения респираторных заболеваний, связанных с интерлейкином-6
US12551533B2 (en) Intranasal neuropeptides for use in stress-related impairments
JP2024539242A (ja) 慢性腎疾患の治療のための改変カベオリン－１ペプチド
US20070249528A1 (en) Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils
RU2770364C1 (ru) Способ лечения болезней легких ингаляционным введением мезенхимальных стромальных клеток и гексапептида
US20200109170A1 (en) Short synthetic peptide and uses thereof
WO2021211006A1 (en) Inhaled hexapeptide for treating interleukin-6 related respiratory diseases
US20190282616A1 (en) Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000